aprepitant
Showing 1 - 25 of 83
Obesity, Nausea and Vomiting, Postoperative Trial in Mexico City (Aprepitant, Placebo)
Active, not recruiting
- Obesity
- Nausea and Vomiting, Postoperative
- Aprepitant
- Placebo
-
Mexico City, MexicoHospital General Tlahuac
Mar 6, 2023
Breast Cancer Trial in Shanghai (Aprepitant, Mirtazapine)
Completed
- Breast Cancer
- Aprepitant
- Mirtazapine
-
Shanghai, ChinaFudan University Cancer Hospital
Apr 19, 2022
Postoperative Nausea, Vomiting Trial in Ankara (Aprepitant, Granisetron)
Not yet recruiting
- Postoperative Nausea
- Vomiting
- Aprepitant
- Granisetron
-
Ankara, TurkeyBaskent University Ankara Hospital
Nov 18, 2022
Heart Failure Trial in New Haven (LCZ 696, Placebo, Para-aminohippurate)
Recruiting
- Heart Failure
- LCZ 696
- +4 more
-
New Haven, ConnecticutYale New Haven Hospital
Dec 27, 2022
Pruritus Trial in Berlin (Aprepitant, Placebo)
Completed
- Pruritus
- Aprepitant
- Placebo
-
Berlin, GermanyAllergie-Zentrum-Charité, Charité - Universitätsmedizin Berlin
Jun 28, 2021
Nausea With Vomiting Chemo-Induced Trial in Wuhan (Ondansetron every 3 weeks, Aprepitant, Dexamethasone)
Not yet recruiting
- Nausea With Vomiting Chemotherapy-Induced
- Ondansetron every 3 weeks
- +3 more
-
Wuhan, Hubei, ChinaHubei Cancer Hospital
Oct 8, 2023
Opioid Dependence Trial in New York (Aprepitant, Placebo pill)
Completed
- Opioid Dependence
- Aprepitant
- Placebo pill
-
New York, New YorkBellevue Hospital Center & the NYU School of Medicine
Aug 17, 2021
Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)
Not yet recruiting
- Breast Cancer
- Chemotherapy-induced Nausea and Vomiting
- Aprepitant
- +2 more
-
Hanzhou, Zhejiang, Chinathe Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023
Chemo-induced Nausea and Vomiting Trial in Moscow (Ondansetron, Dexamethasone, Aprepitant)
Recruiting
- Chemotherapy-induced Nausea and Vomiting
- Ondansetron
- +3 more
-
Moscow, Russian FederationZhukov Nikolay
Jul 27, 2022
NSCLC Trial in GuangZhou (Aprepitant, Desloratadine, Placebo of aprepitant)
Completed
- Non-small Cell Lung Cancer
- Aprepitant
- +3 more
-
GuangZhou, Guangdong, ChinaCancer Center of Sun-Yat Sen University (CCSYSU)
May 15, 2021
Chemo Induced Nausea and Vomiting, Pediatric Cancer Patients Trial in Shanghai (fosaprepitant, aprepitant, Granisetron plus
Not yet recruiting
- Chemotherapy Induced Nausea and Vomiting
- Pediatric Cancer Patients
- fosaprepitant
- +2 more
-
Shanghai, ChinaShanghai Children's Medical Center
May 5, 2021
Perioperative Optimization Trial in Pittsburgh (dietary supplement, drug, other)
Not yet recruiting
- Perioperative Optimization
- Neuraxial Analgesia
- +11 more
-
Pittsburgh, Pennsylvania
- +3 more
Jan 4, 2023
Type 2 Diabetes, Hypertension Trial in Nashville (Placebo, Sitagliptin, Aprepitant)
Completed
- Type 2 Diabetes Mellitus
- Hypertension
- Placebo
- +3 more
-
Nashville, TennesseeVanderbilt University
Feb 8, 2022
Gastrointestinal Tumors, Chemo-induced Nausea and Vomiting Trial in Guangzhou (Aprepitant, Palonosetron, Dexamethasone)
Completed
- Gastrointestinal Neoplasms
- Chemotherapy-induced Nausea and Vomiting
- Aprepitant
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 3, 2020
Chemo-induced Nausea and Vomiting (CINV) Trial (Granisetron transdermal patch, Palonosetron, Aprepitant)
Not yet recruiting
- Chemotherapy-induced Nausea and Vomiting (CINV)
- Granisetron transdermal patch
- +4 more
- (no location specified)
Jun 2, 2021
Glioblastoma Trial in Ulm (Temozolomide, Aprepitant, Minocycline)
Completed
- Glioblastoma
- Temozolomide
- +9 more
-
Ulm, Baden-Württemberg, GermanyUniversity of Ulm School of Medicine
Oct 4, 2021
Anti-emetic Drug Upon Combination Chemotherapy for Non-small
Completed
- Non-small Cell Lung Cancer
- Aprepitant
-
Otsu, Shiga, JapanShiga University of Medical Science Hospital
Aug 28, 2020
Vomiting, Nausea Post Chemo, Head Neck Cancer Trial in Beijing (Aprepitant)
Completed
- Vomiting
- +2 more
- Aprepitant
-
Beijing, ChinaNational Cancer Center/ Cancer Hospital, Chinese Academy of Medc
Jul 14, 2020
Carcinoma, Non-small Cell Lung Trial in Changsha (Aprepitant, )
Completed
- Carcinoma, Non-small Cell Lung
- Aprepitant
- placebo
-
Changsha, Hunan, ChinaHunan Cancer hospital
Mar 25, 2020
Nausea, Vomiting Trial in Toronto (Aprepitant, Palliative radiation therapy, Granisetron)
Terminated
- Nausea
- Vomiting
- Aprepitant
- +2 more
-
Toronto, Ontario, CanadaOdette Cancer Centre, Sunnybrook Health Sciences Centre
Sep 27, 2019
Antiemetic for Highly Emetogenic Chemo Trial in Bangkok (aprepitant, olanzapine 10 mg, olanzapine 5 mg)
Unknown status
- Antiemetic for Highly Emetogenic Chemotherapy
- aprepitant
- +2 more
-
Bangkok, Thailand
- +1 more
Mar 14, 2019
Gastroparesis Trial in United States (Aprepitant, Placebo)
Completed
- Gastroparesis
- Aprepitant
- Placebo
-
San Francisco, California
- +7 more
Apr 15, 2019
Nausea, Vomiting Trial in Chicago (Aprepitant, Olanzapine, Aprepitant plus Olanzapine)
Unknown status
- Nausea
- Vomiting
- Aprepitant
- +2 more
-
Chicago, IllinoisRush University Medical Center
Jan 24, 2019
Chemo-induced Nausea and Vomiting Trial in New Delhi (Ondansetron, Dexamethasone, Aprepitant)
Completed
- Chemotherapy-induced Nausea and Vomiting
- Ondansetron
- +3 more
-
New Delhi, Delhi, IndiaDr Bra Irch, Aiims, New Delhi
Aug 19, 2019
Healthy Trial in Rochester (Aprepitant, Placebo)
Completed
- Healthy
- Aprepitant
- Placebo
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 10, 2018